These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 31145963)

  • 1. Exploring the chemical space for freeze-drying excipients.
    Meng-Lund H; Holm TP; Poso A; Jorgensen L; Rantanen J; Grohganz H
    Int J Pharm; 2019 Jul; 566():254-263. PubMed ID: 31145963
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Crystallizing amino acids as bulking agents in freeze-drying.
    Horn J; Tolardo E; Fissore D; Friess W
    Eur J Pharm Biopharm; 2018 Nov; 132():70-82. PubMed ID: 30201570
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mannitol as an Excipient for Lyophilized Injectable Formulations.
    Thakral S; Sonje J; Munjal B; Bhatnagar B; Suryanarayanan R
    J Pharm Sci; 2023 Jan; 112(1):19-35. PubMed ID: 36030846
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Influence of Mannitol Hemihydrate on the Secondary Drying Dynamics of a Protein Formulation: A Case Study.
    Srinivasan JM; Wegiel LA; Hardwick LM; Nail SL
    J Pharm Sci; 2017 Dec; 106(12):3583-3590. PubMed ID: 28867201
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Investigation of freeze/thaw-related quality attributes of a liquid biopharmaceutical formulation: the role of saccharide excipients.
    Zhou R; Schlam RF; Yin S; Gandhi RB; Adams ML
    PDA J Pharm Sci Technol; 2012; 66(3):221-35. PubMed ID: 22634588
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of Excipient Interactions on the State of the Freeze-Concentrate and Protein Stability.
    Jena S; Horn J; Suryanarayanan R; Friess W; Aksan A
    Pharm Res; 2017 Feb; 34(2):462-478. PubMed ID: 27981449
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Freeze drying of human serum albumin (HSA) nanoparticles with different excipients.
    Anhorn MG; Mahler HC; Langer K
    Int J Pharm; 2008 Nov; 363(1-2):162-9. PubMed ID: 18672043
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Comparison of Controlled Ice Nucleation Techniques for Freeze-Drying of a Therapeutic Antibody.
    Gitter JH; Geidobler R; Presser I; Winter G
    J Pharm Sci; 2018 Nov; 107(11):2748-2754. PubMed ID: 30055225
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Measurement of the kinetics of protein unfolding in viscous systems and implications for protein stability in freeze-drying.
    Tang XC; Pikal MJ
    Pharm Res; 2005 Jul; 22(7):1176-85. PubMed ID: 16028019
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of crystallizing and non-crystallizing cosolutes on succinate buffer crystallization and the consequent pH shift in frozen solutions.
    Sundaramurthi P; Suryanarayanan R
    Pharm Res; 2011 Feb; 28(2):374-85. PubMed ID: 20927571
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of mannitol crystallization in mannitol-sucrose systems on LDH stability during freeze-drying.
    Al-Hussein A; Gieseler H
    J Pharm Sci; 2012 Jul; 101(7):2534-44. PubMed ID: 22535541
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutual Influence of Mannitol and Trehalose on Crystallization Behavior in Frozen Solutions.
    Jena S; Suryanarayanan R; Aksan A
    Pharm Res; 2016 Jun; 33(6):1413-25. PubMed ID: 26908047
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distinct effects of sucrose and trehalose on protein stability during supercritical fluid drying and freeze-drying.
    Jovanović N; Bouchard A; Hofland GW; Witkamp GJ; Crommelin DJ; Jiskoot W
    Eur J Pharm Sci; 2006 Mar; 27(4):336-45. PubMed ID: 16338123
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of fast and conservative freeze-drying on product quality of protein-mannitol-sucrose-glycerol lyophilizates.
    Horn J; Schanda J; Friess W
    Eur J Pharm Biopharm; 2018 Jun; 127():342-354. PubMed ID: 29522899
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The influence of excipients commonly used in freeze drying on whole blood coagulation dynamics assessed by rotational thromboelastometry.
    Erber M; Lee G
    Clin Chem Lab Med; 2015 Sep; 53(10):1605-11. PubMed ID: 25719321
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Screening of novel excipients for freeze-dried protein formulations.
    Holm TP; Meng-Lund H; Rantanen J; Jorgensen L; Grohganz H
    Eur J Pharm Biopharm; 2021 Mar; 160():55-64. PubMed ID: 33508435
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stabilization of rasburicase and physico-chemical characterization of the resulting injectable formulation.
    Bayol A; Breul T; Dupin P; Menegotto J; Aleman C; Duplaa H; Faure P; Bonnet MC; Bauer M
    Drug Dev Ind Pharm; 2004 Sep; 30(8):877-89. PubMed ID: 15521333
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of the active pharmaceutical ingredient concentration on the physical state of mannitol--implications in freeze-drying.
    Liao X; Krishnamurthy R; Suryanarayanan R
    Pharm Res; 2005 Nov; 22(11):1978-85. PubMed ID: 16132343
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of freezing procedure and annealing on the physico-chemical properties and the formation of mannitol hydrate in mannitol-sucrose-NaCl formulations.
    Hawe A; Friess W
    Eur J Pharm Biopharm; 2006 Nov; 64(3):316-25. PubMed ID: 16875806
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of subambient differential scanning calorimetry to monitor the frozen-state behavior of blends of excipients for freeze-drying.
    Martini A; Kume S; Crivellente M; Artico R
    PDA J Pharm Sci Technol; 1997; 51(2):62-7. PubMed ID: 9146035
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.